This HTML5 document contains 103 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n11http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q70862348
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu n'agostu de 1995 наукова стаття, опублікована в серпні 1995 scientific article published on 01 August 1995 wetenschappelijk artikel im August 1995 veröffentlichter wissenschaftlicher Artikel article scientifique publié en 1995
p:P577
wds:Q70862348-634914C7-F3FB-4539-8245-1FF9A293E588
wdt:P577
1995-08-01T00:00:00Z
p:P2860
wds:Q70862348-F2BA8A0E-DAF2-4FB4-B61E-3965BE3010B4 wds:Q70862348-F548696B-6210-45E5-833B-00618F676ECE wds:Q70862348-F696F902-76A7-4016-A5A8-83FB4B31EA41 wds:Q70862348-FD5C37E2-F13E-42A5-B502-95E5861455D0 wds:Q70862348-BB4D2150-7BF1-468F-9158-5B20A5A9A4AF wds:Q70862348-E40B2BC9-2F33-4A20-87C0-EFB919065884 wds:Q70862348-E79A6AD9-701C-4EA8-869C-BE12E903D55F wds:Q70862348-6D4A6748-F9D2-46EB-A14D-46C16D15B92A wds:Q70862348-766F00DF-BA8E-4698-8A85-9BE23CCD3385 wds:Q70862348-78A35637-4C2F-4534-A693-44D4345C9789 wds:Q70862348-7CDA9266-B4EB-4802-A75C-4281853362FB wds:Q70862348-A2FC4518-2612-4F06-8EEC-BAEF4EE352C9 wds:Q70862348-45049029-3B6A-4F3E-AE8B-27F19E9AEA2A wds:Q70862348-54736869-B953-424D-A5B1-E45D23FFA505 wds:Q70862348-5F20F047-F260-4D2A-B616-F8F93ABB12A5 wds:Q70862348-6834E8B7-6403-4D7F-AA95-71BD6FB0CEB5 wds:Q70862348-1A422B7B-1949-465C-84C5-0FEABCABC36B wds:Q70862348-1C4BCEE4-A01C-445E-BAF1-9AA65CF8DD81 wds:Q70862348-1C723E4D-E93E-485A-A6FA-F87103BF4677 wds:Q70862348-26A78CF3-476D-40ED-811E-BB28F24DE6B5 wds:Q70862348-4123EDF3-6749-44F5-A94D-E8CAEDA22899 wds:Q70862348-07B59CBE-5A17-43E5-9B3B-B80E9304E674 wds:Q70862348-0A69B499-A6D4-403F-A8D9-F04C0D752619 wds:Q70862348-135BECEC-243B-4117-B3B9-C0834B535BA5 wds:Q70862348-148D71D3-AFF8-4466-B0D2-D09285DC1A77 wds:Q70862348-160830F8-2AB6-4600-B51B-7F4BD75AD5D4
wdt:P2860
wd:Q43607094 wd:Q44787981 wd:Q36303974 wd:Q52654144 wd:Q68857237 wd:Q68857763 wd:Q35574869 wd:Q67523664 wd:Q69914173 wd:Q71261377 wd:Q44645984 wd:Q71742083 wd:Q70467387 wd:Q34539986 wd:Q69919660 wd:Q34244448 wd:Q44508731 wd:Q44334723 wd:Q69013550 wd:Q44362305 wd:Q93861589 wd:Q67523344 wd:Q47384585 wd:Q28320303 wd:Q93617320 wd:Q53017854
p:P2093
wds:Q70862348-60DADF51-2BD8-4956-965A-2BB0FE09D672 wds:Q70862348-4BEFFABB-32BE-4E1D-8F1D-284553602FB3 wds:Q70862348-422FE7F7-B0F4-49B7-AC97-8AE34D5640A5 wds:Q70862348-2254ED82-4F43-4A44-9C9F-E6F78314D7A1 wds:Q70862348-E6FE04C0-49CA-44CD-917B-030DE2CE711D wds:Q70862348-B770B516-A492-4AEA-9697-20A046C16B45 wds:Q70862348-E80C65D5-675E-470D-A238-81460E7D79CC
wdt:P2093
B Rabinowitz S Behar U Goldbourt H Reicher-Reiss J Leor E Kaplinsky V Boyko
rdfs:label
Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial
skos:prefLabel
Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial
schema:name
Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial
p:P1476
wds:Q70862348-BAF22C6B-C8DB-46D1-9A34-43C1285D360B
wdt:P1476
Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial
p:P304
wds:Q70862348-0344D207-4BE8-4C1F-A0FB-95787F80DB3B
wdt:P304
609-617
p:P31
wds:Q70862348-F4F1CD44-F81B-449D-BD92-95175A09106D
wdt:P31
wd:Q13442814
p:P921
wds:Q70862348-ABFDDEED-D986-47C7-8692-44952635517C wds:Q70862348-DFC01BF1-9B07-42F7-B909-AB28020E85B8
wdt:P921
wd:Q18558122 wd:Q39111
p:P698
wds:Q70862348-2C02E28F-43ED-4ED0-959B-6E090B6BE56D
wdtn:P698
n10:8547212
wdt:P698
8547212
p:P1433
wds:Q70862348-D823B32E-88F7-4CE1-A95A-24CC77013084
wdt:P1433
wd:Q2473050
p:P433
wds:Q70862348-9C2F38BC-4AE8-4D86-9523-1F3EC734A64F
p:P478
wds:Q70862348-5CD7C787-9572-4029-ADE2-52B25CD1C8D5
wdt:P433
4
wdt:P478
9
p:P356
wds:Q70862348-7B4AD640-2FF8-4156-8743-677F0D21D58D
wdtn:P356
n11:BF00878094
wdt:P356
10.1007/BF00878094